The influence of Helicobacter pylori eradication on soluble CD40 ligand and oxidative stress: a step forward to prevent atherosclerosis.
Eshraghian
Ahad
A
Eshraghian
Hamed
H
D000328:Adult; D050197:Atherosclerosis / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D050218:Body Fat Distribution; D023201:CD40 Ligand / Q000032:analysis / Q000378:metabolism*; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D020738:Leptin / Q000032:analysis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology*; D010437:Peptic Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D011379:Prognosis
D015415:Biomarkers; D001786:Blood Glucose; D020738:Leptin; D023201:CD40 Ligand